AbbVie Statistics

Total Valuation

AbbVie has a market cap or net worth of MXN 6.08 trillion. The enterprise value is 7.18 trillion.

Market Cap	6.08T
Enterprise Value	7.18T

Important Dates

The next confirmed earnings date is Wednesday, April 29, 2026.

Earnings Date	Apr 29, 2026
Ex-Dividend Date	Apr 15, 2026

Share Statistics

Current Share Class	1.77B
Shares Outstanding	n/a
Shares Change (YoY)	n/a
Shares Change (QoQ)	+0.11%
Owned by Insiders (%)	0.07%
Owned by Institutions (%)	75.33%
Float	1.77B

Valuation Ratios

The trailing PE ratio is 80.70 and the forward PE ratio is 13.90.

PE Ratio	80.70
Forward PE	13.90
PS Ratio	5.52
PB Ratio	-104.65
P/TBV Ratio	n/a
P/FCF Ratio	18.96
P/OCF Ratio	17.75
PEG Ratio	n/a

Enterprise Valuation

The stock's EV/EBITDA ratio is 13.93, with an EV/FCF ratio of 22.39.

EV / Earnings	95.28
EV / Sales	6.75
EV / EBITDA	13.93
EV / EBIT	19.55
EV / FCF	22.39

Financial Position

The company has a current ratio of 0.67

Current Ratio	0.67
Quick Ratio	0.41
Debt / Equity	n/a
Debt / EBITDA	2.31
Debt / FCF	3.84
Interest Coverage	7.30

Financial Efficiency

Return on equity (ROE) is 6,225.00% and return on invested capital (ROIC) is 22.49%.

Return on Equity (ROE)	6,225.00%
Return on Assets (ROA)	9.81%
Return on Invested Capital (ROIC)	22.49%
Return on Capital Employed (ROCE)	23.29%
Weighted Average Cost of Capital (WACC)	5.66%
Revenue Per Employee	19.32M
Profits Per Employee	1.32M
Employee Count	57,000
Asset Turnover	0.45
Inventory Turnover	3.80

Taxes

In the past 12 months, AbbVie has paid 42.56 billion in taxes.

Income Tax	42.56B
Effective Tax Rate	35.83%

Stock Price Statistics

The stock price has decreased by -2.63% in the last 52 weeks. The beta is 0.36, so AbbVie's price volatility has been lower than the market average.

Beta (5Y)	0.36
52-Week Price Change	-2.63%
50-Day Moving Average	3,813.75
200-Day Moving Average	3,868.14
Relative Strength Index (RSI)	34.23
Average Volume (20 Days)	328

Short Selling Information

Short Interest	n/a
Short Previous Month	n/a
Short % of Shares Out	n/a
Short % of Float	n/a
Short Ratio (days to cover)	3.07

Income Statement

In the last 12 months, AbbVie had revenue of MXN 1.10 trillion and earned 75.36 billion in profits. Earnings per share was 42.49.

Revenue	1.10T
Gross Profit	788.59B
Operating Income	380.14B
Pretax Income	118.77B
Net Income	75.36B
EBITDA	526.67B
EBIT	380.14B
Earnings Per Share (EPS)	42.49

Balance Sheet

The company has 94.64 billion in cash and 1.23 trillion in debt, giving a net cash position of -1,136.78 billion.

Cash & Cash Equivalents	94.64B
Total Debt	1.23T
Net Cash	-1,136.78B
Net Cash Per Share	n/a
Equity (Book Value)	-58.11B
Book Value Per Share	-33.30
Working Capital	-256.13B

Cash Flow

In the last 12 months, operating cash flow was 342.60 billion and capital expenditures -21.86 billion, giving a free cash flow of 320.75 billion.

Operating Cash Flow	342.60B
Capital Expenditures	-21.86B
Depreciation & Amortization	141.55B
Net Borrowing	-5.29B
Free Cash Flow	320.75B
FCF Per Share	n/a

Margins

Gross margin is 71.62%, with operating and profit margins of 34.52% and 6.91%.

Gross Margin	71.62%
Operating Margin	34.52%
Pretax Margin	10.79%
Profit Margin	6.91%
EBITDA Margin	47.83%
EBIT Margin	34.52%
FCF Margin	29.13%

Dividends & Yields

This stock pays an annual dividend of 121.64, which amounts to a dividend yield of 3.56%.

Dividend Per Share	121.64
Dividend Yield	3.56%
Dividend Growth (YoY)	-1.88%
Years of Dividend Growth	2
Payout Ratio	275.84%
Buyback Yield	n/a
Shareholder Yield	3.56%
Earnings Yield	1.24%
FCF Yield	5.27%

Dividend Details

Stock Splits

This stock does not have any record of stock splits.

Last Split Date	n/a
Split Type	n/a
Split Ratio	n/a

Scores

AbbVie has an Altman Z-Score of 2.26 and a Piotroski F-Score of 8. A Z-score under 3 suggests an increased risk of bankruptcy.

Altman Z-Score	2.26
Piotroski F-Score	8